Application of non-natural chaperonin in exogenous expression of saccharomyces cerevisiae

By integrating CYP11A1 and CPR genes from different sources in Saccharomyces cerevisiae, using CRISPR-Cas9 technology to optimize amino acid sequence and codon preferences, the problem of limited CYP11A1 activity in Saccharomyces cerevisiae is solved, and efficient production of pregnenolone is achieved. Natural chaperone protein CPR significantly improves yield and catalytic effects.

CN118909813APending Publication Date: 2024-11-08TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202411144137.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

When CYP11A1 is expressed in exogenously in Saccharomyces cerevisiae, the localization heterogeneity of the natural chaperone proteins Adx and AdR leads to poor electron transfer efficiency, and the lack of cofactor [2Fe-2S] limits the activity of the enzyme, and the prior art is difficult to effectively improve it active.

Method used

Using non-natural chaperone protein CPR as the auxiliary protein of CYP11A1, the gene editing of CYP11A1 and CPR from different sources is integrated into the Saccharomyces cerevisiae genome, and the CRISPR-Cas9 technology is used for gene editing, optimize the amino acid sequence and codon preferences, and realize the effective combination of CYP11A1 and CPR. Expression to avoid dependence of cofactor [2Fe-2S].

Benefits of technology

The activity of CYP11A1 in Saccharomyces cerevisiae and the yield of pregnenolone is improved. The non-natural chaperone CPR is more suitable for assisting CYP11A1 in producing pregnenolone than the natural chaperone tAdx and tAdR, which significantly improves the yield and enhances the catalytic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005001753380000041
    Figure BDA0005001753380000041
  • Figure BDA0005001753380000051
    Figure BDA0005001753380000051
  • Figure HDA0005001753390000011
    Figure HDA0005001753390000011
Patent Text Reader

Abstract

The invention belongs to the technical field of biology, and particularly relates to application of non-natural chaperonin in improvement of exogenous expression activity of P450scc saccharomyces cerevisiae. A coding gene of CYP11A1 and a coding gene of CPR are integrated on a genome of recombinant saccharomyces cerevisiae, so that the purpose of improving the activity of P450scc in exogenous expression of the saccharomyces cerevisiae is achieved. Researches show that when CYP11A1 is expressed by saccharomyces cerevisiae, non-natural chaperonin CPR is more suitable for assisting CYP11A1 in producing pregnenolone than natural chaperonin tAdx and tAdR, so that the invention is completed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to the application of non-natural chaperone proteins in improving the exogenous expression activity of P450scc brewer's yeast. Background Art

[0002] P450scc is composed of cholesterol side-chain cleavage enzyme CYP11A1 and its partner proteins Adx and AdR. It is responsible for catalyzing the first step of the steroid hormone production pathway in vertebrates, namely the production of cholesterol to pregnenolone in mitochondria, and is also an important rate-limiting step in this pathway. When CYP11A1 is exogenously expressed in Saccharomyces cerevisiae, CYP11A1 is truncated to localize it in the cell due to substrate supply (Duport, C. et al., Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast. Nat Biotechnol 1998, 16 (2), 186-9.). At this time, its natural chaperone proteins Adx and AdR must also be localized in the cell using the same truncation method. However, the truncated form of Adx, tAdx, has poor function due to the low intracellular [2Fe-2S] content. Although it is possible to increase the activity of P450scc by increasing the intracellular [2Fe-2S], its activity is still limited by the different localization of multiple chaperone proteins in the cell (CN202211411488.8). In order to solve this problem, it is hoped that the number of P450 chaperone proteins is as small as possible, and it is best that the enzyme itself can take into account the reduction function of the chaperone protein.

[0003] The chaperone protein of endoplasmic reticulum P450 has only one CPR (Cytochrome P450 reductases) and does not require cofactor [2Fe-2S] to help fold. If CYP11A1 can make good use of CPR for catalysis, it can not only circumvent the catalytic limitation of cofactor [2Fe-2S] on CYP11A1, but also avoid the poor electron transfer efficiency caused by the different positioning and limited contact of Adx and AdR. Regarding whether CYP11A1 can use CPR as a chaperone, there are two completely different results: Yablokov et al. reported that BtCYP11A1 can interact with CPR protein in vitro, but the combination of the two has no catalytic activity (Yablokov, EO et al., A large-scale comparative analysis of affi nity, thermodynamics and functional characteristics of interactions of twelvecytochrome P450isoforms and their redox partners. Biochimie 2019, 162, 156-166.), but Li et al. reported that the combination of BbgCYP11A1 (Bufo bufogargarizans Cantor) and AaCPR (Anemarrhena asphodeloides) can successfully produce pregnenolone in Saccharomyces cerevisiae without the participation of Adx and AdR (Li, G, et al, Transcriptome Analysis and Identification of the Cholesterol Side Chain Cleavage Enzyme BbgCYP11A1 From Bufo bufogargarizans. Front Genet 2022,13,828877.). Summary of the invention

[0004] In order to verify the utilization of CPR by cholesterol side-chain cleavage enzyme CYP11A1, this experiment selected CYP11A1 from 4 sources and CPR from 4 sources for combined verification. Among them, the truncated wild boar-derived tSsCYP11A1 was shown to be the best when exogenously expressed in yeast to produce pregnenolone (Zhang, R.; Zhang, Y.; Wang, Y.; Yao, M.; Zhang, J.; Liu, H.; Zhou, X.; Xiao, W.; Yuan, Y., Pregnenolone Overproduction in Yarrowia lipolytica by Integrative Components Pairing of the Cytochrome P450scc System. ACS SynthBiol 2019, 8(12), 2666-2678.), and the AoCPR from Absidia orchidis performed best in the whole-cell catalytic production of hydrocortisone in Saccharomyces cerevisiae (Chen, J. et al, Identification of Absidia orchidis steroid11β-hydroxylation system and its application in engineering Saccharomyces cerevisiae for one-step biotransformation to produce hydrocortisone. Metab Eng 2020, 57, 31-42.). At the same time, in order to compare the differences in electron transfer efficiency between CYP11A1 and its own chaperone proteins Adx, AdR and non-natural chaperone protein CPR, truncated bovine Adx and AdR were selected as controls.

[0005] The sources of CYP11A1 are as follows: (1) BbgCYP11A1 from Chinese giant toad (Bufo bufogargarizans Cantor), (2) HmCYP11A1 from human (Homo sapiens), (3) BtCYP11A1 from cattle (Bos taurus), and (4) SsCYP11A1 from wild boar (Sus sus scrofa).

[0006] The sources of CPR are as follows: (1) VvCPR from grape (Vitis vinifera L), (2) AoCPR from Anemarrhena asphodeloides, (3) AoCPR from Absidia coerulea, and (4) CPR-NCP1 from Saccharomyces cerevisiae.

[0007] The present invention provides a recombinant brewer's yeast for expressing CYP11A1, characterized in that a coding gene of CYP11A1 and a coding gene of CPR are integrated into the genome of the recombinant brewer's yeast.

[0008] Specifically, the CYP11A1 is: BbgCYP11A1 from Bufo bufogargarizans Cantor, HmCYP11A1 from Homo sapiens, BtCYP11A1 from Bos taurus or SsCYP11A1 from Sus sus scrofa, or a fragment thereof having 2-38 amino acid residues at the N-terminus truncated and active;

[0009] Preferably, the amino acid sequence is shown in any one of SEQ ID NOs: 4-7;

[0010] Furthermore, the coding gene was optimized according to the codon usage preference of Saccharomyces cerevisiae.

[0011] In another specific embodiment, the CPR is: VvCPR from grape (Vitis vinifera L), AoCPR from Anemarrhena asphodeloides, AoCPR from Absidia coerulea or CPR-NCP1 of Saccharomyces cerevisiae.

[0012] Preferably, its sequence is shown in any one of SEQ ID NOs: 8-10.

[0013] Preferably, the integration is inserted into the ATF2 site of the Saccharomyces cerevisiae genome, for example, by gene editing.

[0014] Specifically, the starting Saccharomyces cerevisiae is a recombinant strain producing 22R-hydroxycholesterol, and more specifically, genes StDWF5, GgD HCR24 and VcCYP90B27 are integrated into the genome;

[0015] More preferably, the gene is optimized according to the codon usage preference of Saccharomyces cerevisiae; specifically, the gene StDWF5 (preferably its nucleotide sequence is as shown in SEQ ID NO: 1), GgDHCR24 (preferably its nucleotide sequence is as shown in SEQ ID NO: 2) and gene VcCYP90B27 (preferably its nucleotide sequence is as shown in SEQ ID NO: 3) are introduced into the ERG5 site of Saccharomyces cerevisiae BY4742 by gene editing method.

[0016] The present invention also provides a method for preparing pregnenolone, which comprises the step of culturing the recombinant cerevisiae yeast to make it produce pregnenolone.

[0017] Optionally, the step of isolating the produced pregnenolone is further included.

[0018] Specifically, the culture conditions are 28-32°C, 240-260rpm in YPD culture, and ethanol and galactose are added to the YPD culture. The step of isolating the produced CYP11A1 is to collect the precipitate by centrifugation, then add glass beads and an extractant, crush and sonicate, and filter with an organic filter membrane to obtain CYP11A1. Preferably, glass beads and an extractant with a methanol: acetone ratio of 1:1 (v / v) are added in an equal volume to the bacterial cells, crushed for 5 minutes twice, sonicated for 30 minutes, and filtered with an organic filter membrane to obtain pregnenolone.

[0019] The present invention shows that when CYP11A1 is exogenously expressed in Saccharomyces cerevisiae, the non-natural chaperone protein CPR seems to be more suitable than the natural chaperone proteins tAdx and tAdR to assist CYP11A1 in producing pregnenolone, thereby ultimately achieving the purpose of increasing the production of pregnenolone, thus completing the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 : Map of the CRISPR plasmids used.

[0021] Figure 2:The corresponding yield of recombinant strains producing pregnenolone; tBtAdx: truncated bovine Adx; tBtAdR: truncated bovine AdR; BbgCYP11A1: CYP11A1 from Chinese giant toad; tBbg BbgCYP11A1: truncated CYP11A1 from Chinese giant toad; HmCYP11A1: CYP11A1 from human; tHmCYP11A1: truncated CYP11A1 from human; SsCYP11A1: CYP11A1 from wild boar; tSsC YP11A1: truncated CYP11A1 from wild boar; BtCYP11A1: CYP11A1 from cattle; AaCPR: CYP11A1 from Anemarrhena asphodeloides; AoCPR: CPR from Absidia cyanobacteria; VvCPR: CPR from grape; NCP1: CPR endogenous to Saccharomyces cerevisiae.

[0022] Figure 3 :An overview of the shake flask fermentation results of the recombinant Saccharomyces cerevisiae strain producing pregnenolone.

[0023] Example 1: CYP11A1 can use non-native CPR as a chaperone protein when heterologously expressed in Saccharomyces cerevisiae and has a better catalytic effect than the natural chaperone protein

[0024] The existing technology (Xu, L. et al. Metabolic Engineering of Saccharomyces cerevisiae for Gram-Scale Diosgenin Production, MetabEng 2022, 70, 115-128) identified three key genes, namely, the sterol C-7 reductase gene StDWF5 from potato (Solanum tuberosum L.), the GgDHCR24 gene encoding sterol C-24 reductase from Gallus gallus, and the VcCYP90B27 gene from Veratrum californicum. These three genes can be co-expressed exogenously in Saccharomyces cerevisiae to synthesize 22-R hydroxycholesterol.

[0025] In this experiment, CRISPR-Cas9 technology was used (for methods, see Chinese patent CN202211411488.8) to introduce these three genes StDWF5 (SEQ ID NO: 1, note that the relevant sequences have been optimized according to the codon usage preference of Saccharomyces cerevisiae), GgDHCR24 (SEQ ID NO: 2) and gene VcCYP90B27 (SEQ ID NO: 3) into the ERG5 site of Saccharomyces cerevisiae BY4742 to form a recombinant strain LPG002 that produces 22R-hydroxycholesterol. The genotype is shown in Table 1.

[0026] Furthermore, using LPG002 as the starting strain, the study introduced a truncated wild boar-derived tSsCYP11A1 gene (SEQ ID NO: 6, with 2-38 amino acid residues at its N-terminus deleted) at the ATF2 locus through CRISPR-Cas9 technology, and simultaneously introduced the tSsCYP11A1 gene and natural chaperone proteins tAdx and tAdR (these two sequences are described in Chinese patent CN202211411488.8), thereby obtaining recombinant strains tSsCYP11A1 and tSsCYP11A1-tBtAdx-tBtAdR capable of producing pregnenolone. The genotypes are shown in Table 1. In order to explore the use of non-natural chaperone protein CPR for electron transfer in the production of pregnenolone by CYP11A1, a series of full-length and truncated CYP11A1 from different sources (for specific sequences, see SEQ ID NO: 4-7, the truncated form of CYP11A1 deleted the N-terminal 2-38 amino acid residues) and CPR from different sources (for sequences, see SEQ ID NO: 5-6) were inserted into the ATF2 locus using LPG002 as the starting strain. NO:8-10 are AaCPR, AoCPR and VvCPR, including NCP1 of Saccharomyces cerevisiae itself, SGD: S000001084, website yeastgenome (SDG) https: / / www.yeastgenome.org / locus / S000001084), and 7 (Bbg, tBbg, Hm, tHm, Ss, tSs, Bt) CYP11A1 × 4 [(Aa, Ao, Vv) CRP + NCP1] = 28 strains were obtained by combined expression. The 28 recombinant strains producing pregnenolone are the strains with sequence numbers 4-31 in Table 1, with LPG002, ATF2::T ADH1 -BbgCYP11A1-P GAL10 / 1 -AaCPR-T FBA1 For example, AoCPR and CYP11A1 were inserted separately, where AoCPR was driven by promoter PGAL1 and CYP11A1 was driven by promoter PGAL10. In Saccharomyces cerevisiae, this promoter is marked PGAL10 / 1, indicating that a sequence is PGAL1 in the forward direction and PGAL10 in the reverse direction. So far, I have obtained 30 recombinant strains that produce pregnenolone and conducted fermentation verification on them. The specific fermentation method is as follows:

[0027] Pick the bacteria into a 3 ml YPD test tube and culture overnight at 30°C, 250 rpm. Measure the OD of the bacterial solution in the test tube the next day. 600 , the bacterial solution was adjusted according to the initial OD 6000.1 was inoculated into 15 ml YPD liquid and cultured at 30°C, 250 rpm for 2 days. The bacterial liquid was then placed in a 50 ml sterile centrifuge tube, centrifuged at 5000 rpm, 5 min to remove the supernatant, and 15 ml YP + 2% (g / v) ethanol + 1% (g / v) galactose was added to the bacteria and cultured for three days.

[0028] Then take 2 ml of fermentation broth, centrifuge at 12000 rpm for 1 min, remove the supernatant, wash twice with distilled water, then add glass beads and 1 ml of extractant (methanol: acetone = 1:1 (v / v)) with an equal volume to the bacteria, crush for 5 min twice, ultrasonicate for 30 min, filter with an organic filter membrane, and then perform GC detection (Shimadzu, maintain at 100 °C for 1 min, heat to 300 °C at 50 °C / min, and then maintain for 40 min).

[0029] The data results are shown in Figure 2 The results showed that strain tSsCYP11A1 could produce pregnenolone without the participation of additional chaperone proteins, with a yield of 1.44 mg / L; on this basis, the strain tSsCYP11A1-tBtAdx-tBtAd R, which introduced its natural chaperone proteins tAdx and tAdR, produced 1.69 mg / L of pregnenolone, and the yield of pregnenolone did not increase significantly. On the other hand, the recombinant strains that introduced CYP11A1 from different sources and non-natural CPRs to produce pregnenolone, except for the bovine BtCYP11A1 that could not use the four different CPRs to synthesize pregnenolone as reported in the article, the CYP11A1 from the other three sources, whether full-length or truncated, could use the four different CPRs to express pregnenolone. It was determined that CYP11A1 from most sources can use the non-natural chaperone protein CPR to transfer electrons.

[0030] at the same time Figure 2 The results showed that the top three recombinant strains with the best pregnenolone production performance were BbgCYP11A1-AaCPR, HmCYP11A1-AaC PR and tSsCYP11A1-AoCPR, with production of 6.88 mg / L, 5.91 mg / L and 5.90 mg / L respectively, which were much higher than the 1.69 mg / L of pregnenolone produced by its natural chaperone protein combination strain tSsCYP11A1-tBtAdx-tBtAdR. This proves that when CYP11A1 is exogenously expressed in Saccharomyces cerevisiae, the non-natural chaperone protein CPR is more suitable than the natural chaperone proteins tAdx and tAdR to assist CYP11A1 in producing pregnenolone.

[0031] Table 1: Figure 2 Genotypes of strains involved

[0032]

[0033]

[0034] Example 2: The catalytic combination of tSsCYP11A1 and AoCPR in Saccharomyces cerevisiae produces the best effect of pregnenolone

[0035] In order to optimize and determine the optimal CYP11A1-CPR combination, we focused on the top three recombinant strains that showed the highest pregnenolone production efficiency in previous experiments: BbgCYP11A1-AaCPR, HmCYP11A1-AaCPR and tSsCYP11A1-AoCPR. In order to further enhance the industrial application potential of these strains, especially to reduce their dependence on galactose as a carbon source, we used CRISPR-Cas9 technology to knock out the GAL1, GAL7 and GAL10 gene clusters, named FC051, FC052 and FC053, respectively. The specific genotypes are shown in Table 2.

[0036] Table 2: Figure 3 Genotypes of strains involved

[0037] name sequence FC051 <![CDATA[LPG002,ATF2::T ADH1 -BbgCYP11A1-P GAL10 / 1 -AaCPR-T FBA1 ,ΔGAL1-7-10]]> FC052 <![CDATA[LPG002,ATF2::T ADH1 -HmCYP11A1-P GAL10 / 1 -AaCPR-T FBA1 ,ΔGAL1-7-10]]> FC053 <![CDATA[LPG002,ATF2::T ADH1 -tSsCYP11A1-P GAL10 / 1 -AoCPR-T FBA1 ,ΔGAL1-7-10]]>

[0038] FC051, FC052 and FC053 were fermented and then sampled. The GC test results were as follows: Figure 3 Among them, FC 053 had the highest yield of 10.57 mg / L, indicating that tSsCYP11A1 and AoCPR are the best combination for producing pregnenolone, which can provide guidance for the subsequent high production of steroid compounds in Saccharomyces cerevisiae.

Claims

1. A recombinant Saccharomyces cerevisiae, characterized in that The genes encoding CYP11A1 and CPR are integrated into its genome.

2. The recombinant Saccharomyces cerevisiae according to claim 1, characterized in that The CYP11A1 is: BbgCYP11A1 from Bufo bufogargarizans Cantor, HmCYP11A1 from Homo sapiens, BtCYP11A1 from Bos taurus or SsCYP11A1 from Sus sus scrofa, or a fragment thereof having 2-38 amino acid residues at the N-terminus and being active; Preferably, its amino acid sequence is shown in any one of SEQ ID NOs: 4-7; Furthermore, the coding gene was optimized according to the codon usage preference of Saccharomyces cerevisiae.

3. The recombinant Saccharomyces cerevisiae according to claim 1, characterized in that The CPR is: VvCPR from grape (Vitis vinifera L ), AoCPR from Anemarrhena asphodeloides , AoCPR from Absidia coerulea , or CPR-NCP1 from Saccharomyces cerevisiae ; Preferably, its sequence is shown in any one of SEQ ID NOs: 8-10.

4. The recombinant Saccharomyces cerevisiae according to any one of claims 1 to 3, characterized in that The integration is insertion into the ATF2 site of the Saccharomyces cerevisiae genome.

5. The recombinant Saccharomyces cerevisiae according to any one of claims 1 to 3, characterized in that The starting Saccharomyces cerevisiae is a recombinant strain producing 22R-hydroxycholesterol, more specifically, genes StDWF5, GgDHCR24 and VcCYP90B27 are integrated into the genome; More preferably, the gene is optimized according to the codon usage preference of Saccharomyces cerevisiae; specifically, the gene StDWF5 (preferably its nucleotide sequence is as shown in SEQ ID NO: 1), GgDHCR24 (preferably its nucleotide sequence is as shown in SEQ ID NO: 2) and gene VcCYP90B27 (preferably its nucleotide sequence is as shown in SEQ ID NO: 3) are introduced into the ERG5 site of Saccharomyces cerevisiae BY4742 by gene editing method.

6. A method for preparing pregnenolone, characterized in that: The method comprises the step of culturing the recombinant Saccharomyces cerevisiae according to any one of claims 1 to 5 so as to produce pregnenolone.

7. The method according to claim 6, characterized in that Also included is the step of isolating the produced pregnenolone.

8. The method according to claim 6, characterized in that Culture conditions: YPD culture at 28-32°C, 240-260 rpm, with ethanol and galactose added.

9. The method according to claim 7, characterized in that The steps of separating the produced pregnenolone are to collect the precipitate by centrifugation, then add glass beads and an extractant, crush and sonicate, and filter with an organic membrane to obtain the pregnenolone.

10. The method according to claim 9, characterized in that The method comprises adding glass beads in an equal volume to the bacterial cells and an extractant composed of methanol:acetone = 1:1 (v / v), crushing for 5 minutes twice, ultrasonicating for 30 minutes, and filtering with an organic filter membrane to obtain pregnenolone.

Citation Information

Cited By

  • Cytochrome P450 cholesterol side chain lyase mutant, progesterone-producing recombinant saccharomyces cerevisiae and application thereof

    CN121086995A

  • Cytochrome P450 cholesterol side chain lyase mutant, progesterone-producing recombinant saccharomyces cerevisiae and application thereof

    CN121406591A

  • Method for synthesizing steroid hormone compound by using saccharomyces cerevisiae

    CN121592690A